Skip Navigation


NDT Advance Access originally published online on March 30, 2006
Nephrology Dialysis Transplantation 2006 21(6):1549-1554; doi:10.1093/ndt/gfl127
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
21/6/1549    most recent
gfl127v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (5)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Patschan, D.
Right arrow Articles by Herget-Rosenthal, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Patschan, D.
Right arrow Articles by Herget-Rosenthal, S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2006]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org


Original Articles: Clinical Nephrology

Acute myocardial infarction in thrombotic microangiopathies—clinical characteristics, risk factors and outcome

Daniel Patschan1, Oliver Witzke1, Ulrich Dührsen2, Raimund Erbel3, Thomas Philipp1 and Stefan Herget-Rosenthal1

1 Department of Nephrology, 2 Department of Haematology and 3 Department of Cardiology, University Hospital, Essen, University of Duisburg-Essen, Germany

Correspondence and offprint requests to: Stefan Herget-Rosenthal, MD, Klinik für Nieren- und Hochdruckkrankheiten, Universitätsklinikum Essen, Hufelandstr. 55, D-45122 Essen, Germany. Email: stefan.herget-rosenthal{at}uni-essen.de

Background. Acute myocardial infarction (AMI) has been reported and is associated with poor outcome in the course of thrombotic microangiopathies (TMA). However, data are very limited in regard to the clinical characteristics, risk factors and outcome of AMI during TMA. Furthermore, current AMI definitions based on troponins are more sensitive and specific to detect myocardial injury.

Methods. We retrospectively analysed 74 consecutive patients with 78 TMA episodes. TMA was defined as platelets below 150 x 109/l, haemolytic anaemia, elevated lactate dehydrogenase (LDH) and increased red cell fragmentation, and AMI as serum troponin I above 1 ng/ml with symptoms of myocardial ischaemia and/or appropriate electrocardiography (ECG) alterations.

Results. AMI occurred in 14 TMA episodes (18%) (9 non- and 5 ST-segment elevation AMI). AMI occurred 5±3 days after TMA diagnosis, predominately in clinically suspected thrombotic thrombocytopenic purpura (TTP) as TMA subtype. Independent risk factors for subsequent AMI were TTP (RR 2.2; 95% CI 1.1–5.6), and serum LDH above 1000 U/l (RR 2.7; 95% CI 1.3–7.2) as well as serum troponin I above 0.20 ng/ml at TMA presentation (RR 13.5; 95% CI 2.6–86.8). LDH above 1000 U/l together with troponin I above 0.20 ng/ml had a sensitivity of 86% (95% CI 60–96%) and a specificity of 95% (95% CI 86–98%) to predict AMI in the later course of TMA. AMI contributed substantially to morbidity causing left ventricular dysfunction in three of eight survivors and potentially accounted for the death in five of six non-survivors.

Conclusions. AMI is an early, frequent and severe complication during TMA. AMI occurs especially in TTP, and serum LDH above 1000 U/l in combination with serum troponin I above 0.20 ng/ml at TMA presentation are excellent predictors of subsequent AMI.

Keywords: myocardial infarction; prediction; thrombotic microangiopathy; thrombotic thrombocytopenic purpura; troponin


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
CirculationHome page
M. Y. Chan, F. Andreotti, and R. C. Becker
Hypercoagulable States in Cardiovascular Disease
Circulation, November 25, 2008; 118(22): 2286 - 2297.
[Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
S. Herget-Rosenthal
Reply
Nephrol. Dial. Transplant., August 1, 2008; 23(8): 2702 - 2703.
[Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
J. Thachil
The role for adjunctive treatment to plasma exchange in thrombotic thrombocytopenic purpura
Nephrol. Dial. Transplant., August 1, 2008; 23(8): 2701 - 2702.
[Full Text] [PDF]


Home page
CirculationHome page
A. O. Spiel, J. C. Gilbert, and B. Jilma
Von Willebrand Factor in Cardiovascular Disease: Focus on Acute Coronary Syndromes
Circulation, March 18, 2008; 117(11): 1449 - 1459.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.